Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
- PMID: 33368396
- PMCID: PMC7986701
- DOI: 10.1002/jmv.26722
Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Conflict of interest statement
James L. Ratcliff is Chairman and CEO of Rowpar Pharmaceuticals, Inc. Jaiprakash G. Shewale is Director of Research and Technical, Rowpar Pharmaceuticals, Inc.
Comment in
-
Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus-2 by Rowpar Pharmaceuticals.J Med Virol. 2021 Apr;93(4):1903-1904. doi: 10.1002/jmv.26762. Epub 2021 Jan 5. J Med Virol. 2021. PMID: 33372690 No abstract available.
Comment on
-
Lowering the transmission and spread of human coronavirus.J Med Virol. 2021 Mar;93(3):1605-1612. doi: 10.1002/jmv.26514. Epub 2020 Oct 5. J Med Virol. 2021. PMID: 32940907
References
-
- Meyers C, Robison R, Milici J, et al. Lowering the transmission and spread of human coronavirus. J Med Virology. 2020:1‐8. https://onlinelibrary.wiley.com/doi/10.1002/jmv.26514 - DOI - PubMed
-
- Wu KJNo. Mouthwash will not save you from the coronavirus. New York Times. October 21, 2020. https://www.nytimes.com/2020/10/21/health/covid-mouthwash.html. Accessed November 16, 2020.
-
- Centers for Disease Control and Prevention . Human coronavirus types. 2020; Feb 15 (page last reviewed). https://www.cdc.gov/coronavirus/types.html. Accessed October 29, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
